Tag: generic drug patents

Generic Drug Patents: How Exclusivity Periods Vary Across Countries

Generic Drug Patents: How Exclusivity Periods Vary Across Countries

Generic drug exclusivity periods vary widely across countries, affecting how quickly affordable versions reach patients. The U.S. uses complex patent stacking and 180-day incentives, while the EU follows a clearer 8+2+1 model. These rules shape drug prices, innovation, and global access.

Read More
Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines

Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines

Patent litigation in generic drug markets is delaying affordable medicines by years. Learn how Orange Book listings, serial lawsuits, and pay-for-delay settlements are shaping access to low-cost drugs-and what’s being done to stop it.

Read More
Categories
Related Store
Archives